The Nurse View: Evolution of Anti-HER2 Therapies in Gastroesophageal Adenocarcinoma

Are you familiar with the most common treatment-related events of emerging HER2-targeted therapies for gastroesophageal adenocarcinoma (GEA)?

Credit available for this activity expires: 3/30/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/nurse-view-evolution-anti-her2-therapies-gastroesophageal-2026a100096j?ecd=bdc_podcast_libsyn_mscpedu